In general, these alternative options may lead to more modest weight loss compared to GLP-1s, but not everyone needs to lose a bunch of weight during this life stage
Steven Greene, a neuroscientist, explains that semaglutides impact on the brains reward system, particularly how it interacts with dopamine, is still poorly understood
Policy The findings support continuing the use of GLP-1 medications in women with metabolic risk factors who are considering pregnancy, says Cara Dolin, MD, a maternal-fetal medicine specialist, and a coauthor of the research, which was presented at the Society of Maternal-Fetal Medicine pregnancy meeting in February 2026
Consulting a healthcare provider is crucial to selecting a safe and effective weight loss solution that aligns with individual health needs and goals
In the model of DKD rat, the administration of ASPs has been observed to result in a reduction in the expression of inflammatory factors, including NF-B, MCP-1, TNF-, and IL-1, in renal tissue, thereby contributing to the alleviation of renal injury
When do clinical differences matter most for real users